Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:51:02 EST Fri 06 Feb 2026
Enter Symbol
or Name
USA
CA



Q:CRMD - CORMEDIX INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CRMD - Q0.15.50·7.940.47.69+0.344.61,574.111,24712,1387.475  7.72  7.4017.43  5.6019:59:28Feb 0215 min RT 2¢

Recent Trades - Last 10 of 12138
Time ETExPriceChangeVolume
19:59:28Q7.66090.310950
19:11:13Q7.690.34300
19:10:51Q7.690.3430
18:03:43Q7.690.3410
18:01:15Q7.690.345
17:55:58Q7.690.34157
17:54:25Q7.610.261
17:28:46Q7.690.3439
17:07:02Q7.68990.339950
16:41:05Q7.610.261

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-02 08:30U:CRMDNews ReleaseCorMedix Therapeutics Announces Share Repurchase Program
2026-01-29 08:30U:CRMDNews ReleaseCorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026
2026-01-09 08:30U:CRMDNews ReleaseCorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
2026-01-08 08:05U:CRMDNews ReleaseCorMedix Therapeutics Announces Leadership and Board Updates
2026-01-08 08:00U:CRMDNews ReleaseCorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates
2025-12-18 08:00U:CRMDNews ReleaseCorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath
2025-11-12 16:05U:CRMDNews ReleaseTalphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
2025-11-12 11:01U:CRMDNews ReleaseStrong Earnings and Biotech Resilience Define the Midweek Momentum
2025-11-12 07:30U:CRMDNews ReleaseCorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance
2025-10-31 08:30U:CRMDNews ReleaseCorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025
2025-10-23 08:30U:CRMDNews ReleaseCorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath
2025-10-21 08:30U:CRMDNews ReleaseTalphera Announces the Appointment of Joe Todisco to Board of Directors
2025-10-20 07:30U:CRMDNews ReleaseCorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance
2025-09-29 08:30U:CRMDNews ReleaseCorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO
2025-09-08 08:30U:CRMDNews ReleaseTalphera Announces Private Placement Financing of up to $29 Million Priced At-the Market
2025-09-08 08:30U:CRMDNews ReleaseCorMedix Announces Strategic Minority Investment in Talphera
2025-09-02 07:30U:CRMDNews ReleaseCorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team
2025-08-28 08:30U:CRMDNews ReleaseCorMedix to Participate in Upcoming Investor Conferences
2025-08-07 07:00U:CRMDNews ReleaseCormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
2025-08-07 07:00U:CRMDNews ReleaseCorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings